At 107.5x earnings with no Forward P/E available, the market is pricing Douglas Emmett as a statistically distorted earnings story rather than a clean growth vehicle. The Altman Z-Score of 0.2 is deep in distress territory, signaling elevated balance sheet risk despite a modest Price/Book of 0.9 that superficially screens as “cheap.” With ROE at just 2.50% and Operating Margin at 0.80%, this is a low-profit REIT carrying equity market skepticism, and the absence of forward valuation metrics suggests limited visibility into near-term earnings stability. This is not a classic mispricing—it looks like a balance-sheet-constrained real estate vehicle trading optically cheap on assets but fundamentally weak on forward earnings power.